w 125 x photoaffinity probe I iodocyanopindololdiazirine. Receptor size was found to be 67 000 and 47 000 Da in the wild-type and 60 000 and 42 000 in the two variant cells. This 6 kDa discrepancy in mass was abolished upon treatment of labeled cell extracts with N-glycosidase F, suggesting the possibility of either N-terminal truncation or altered glycosylation of the receptor in the variant cells. To distinguish between these possibilities, we sequenced the b -adrenergic receptor gene and 
Introduction
The b -adrenergic receptor gene has been cloned 2 w x from several species 1-3 . In each, it is encoded by a single intronless gene, 1.3 kb in length. Transcription-regulating elements are located upstream of the w x open reading frame 2,4 . The receptor contains seven clusters of hydrophobic amino acids, each cluster being of sufficient size to span the plasma membrane.
w x By homology with bacterial rhodopsin 5 , these clusters are postulated to span the membrane. The Nterminal of the b -adrenergic receptor contains two 2 consensus sequences, Asn-X-Ser, for N-glycosylation w x 6,7 . That such glycosylation actually occurs has w x been suggested by experiment [8] [9] [10] [11] . The core polypeptide has a molecular weight of some 47 000 Da. The C-terminal of the receptor contains consensus sequences for phosphorylation by both b-adren-Ž 1 . ergic receptor kinase bARK , on Ser and Thr residues, and by cyclic AMP-dependent protein ki-Ž . w x nase PKA , on the Arg-Arg-Ser-Ser motif 12 .
The b -adrenergic receptor, like many other hor-2 w x mone receptors, is dynamically regulated 13 . Regulation of responsiveness to b -adrenergic agonists 2 occurs at many levels, from gene transcription to regulation of the receptor at the cell surface and w x coupling to the G protein 14,15 . s The S49 murine T lymphoma cell line, along with variants that lack critical functions necessary for hormonal stimulation of cellular response, has provided much insight into the mechanism by which b -adren-2 ergic receptors activate adenylyl cyclase via G s w x 16,17 . The S49 cell has played a seminal role in furthering research into the adrenergic-responsive adenylyl cyclase system due to the isolation of multiple variants along the pathway of cyclic AMP generation and response. and resuspended in 2 ml of this buffer. Each batch of resuspended cells was placed in one of the 3.5 cm diameter wells of a 6 well culture plate and the plate was subjected to UV-irradiation for 10 min on ice. The cells were washed twice more in ice-cold buffer Ž 150 mM NaCl, 20 mM Hepes, 5 mM EDTA, pH . 7.4 and subjected to N cavitation in a Parr bomb. 2 The disrupted cells were centrifuged at 200 = g to remove any intact cells and nuclei. The supernatant was then centrifuged at 35 000 = g. The membrane pellet was resuspended into 0.3 ml water using a 1 ml syringe and a 22-guage needle. The protein concentration was measured and adjusted to 1.25 mgrml. Glycosidase treatment was performed on these memw x brane preparations as described previously 20 . Membranes were incubated with 33 Urml N-glycosidase F for 16 h at 37qC in 100 mM sodium phosphate, pH 6.1, 50 mM EDTA, 200 mM NaCl, 1% Ž . Ž . wrv digitonin, 1% vrv Nonidet P-40, 0.1% SDS, 10 mgrml leupeptin, 5 mgrml pepstatin A and Ž . 0.01% wrv phenylmethylsulfonylfluoride or with 33 Urml endoglycosidase H for 16 h at 378C in the same buffer except that 11 mM sodium citrate pH 5.5 replaced sodium phosphate. One fifth volume of sam-Ž ple loading buffer 375 mM Tris-HCl, 3.6 mM b-. mercaptoethanol, 50% glycerol, 15% SDS, pH 6.8 was added and 200 ml of each sample was loaded onto one lane of a 1.5 mm thick 9% SDS-PAGE discontinuous Laemmli gel and run at 25 V overnight. The labeled bands were visualized by autoradiography.
Receptor solubilization and WGA column chromatography
Approx. 2 P 10 8 S49 cells were collected by centrifugation, washed twice in phosphate-buffered saline, twice in 150 mM NaCl, 20 mM Tris-HCl, 5 mM EDTA, pH 7.4 then subjected to N cavitation in 2 a Parr bomb. The disrupted cells were centrifuged at 200 = g to remove intact cells and nuclei. The resulting supernatant was centrifuged at 35 000 = g. The membrane pellet was resuspended in a Dounce homogenizer at a protein concentration of 1.5 mgrml in 150 mM NaCl, 20 mM Tris-HCl, 5 mM EDTA, pH Ž . Ž . 7.4, 1.2% wrv digitonin, made from a 1.5% wrv w x digitonin solution prepared as described 21 . After 30 min incubation on ice, the suspension was again centrifuged at 35 000 = g and the supernatant retained.
The protein content of the solubilized membrane preparations was determined and equivalent amounts Ž . of protein 0.4-1 mg were passed over columns containing 1 ml immobilized WGA. The eluent was passed over the columns two additional times to maximize b -adrenergic receptor binding and the 2 columns were subsequently washed with 7 ml digi-Ž tonin buffer 100 mM NaCl, 10 mM Tris-HCl, 5 mM Ž . . EDTA, pH 7.4, 0.05% wrv digitonin . Bound receptor was eluted with 5 ml digitonin buffer containing 300 mM N-acetyl-D-glucosamine.
b -Adrenergic receptor inactiÕation protocol 2
A stock solution of BIM was prepared by diluting 20 mM BIM dissolved in 100% methanol to 10 y5 M in 100% ethanol. Cells, at a density of 5 = 10 5 rml, were treated with 10 y8 M BIM. Following a 2-h incubation at 378C, the cells were washed, under sterile conditions, by three successive centrifugations ( )in 100 ml growth medium at room temperature. Following removal of the BIM, the cells were returned to the incubator in normal growth medium. Aliquots were withdrawn at intervals thereafter for assessment of receptor density as described below.
b -Adrenergic receptor binding assay 2
Measurement of b -adrenergic receptor was made 2 w x using intact S49 cells as described previously 19 . Cells were harvested and washed twice in phosphate-buffered saline prior to resuspension in Dulbecco's modified Eagle's medium supplemented Ž . with 0.1% wrv bovine serum albumin and 20 mM Hepes, pH 7.4. Approx. 10 6 cells were incubated Ž . w 125 x with y -I iodocyanopindolol for 1 h in a volume of 0.25 ml at 378C in a shaking water bath. Measurement of solubilized receptor was made in digitonin buffer in a volume of 0.5 ml for 20 h at 4qC. Non-specific binding was defined as that not com-Ž . peted by addition of 1 mM " -propranolol. Membranes were trapped on Whatman GFrC filter paper using a Brandel cell harvester. Solubilized receptor was trapped on the same filter paper pre-soaked in Ž . 10% wrv aq. polyethyleneimine.
Isolation of DNA
High molecular weight genomic DNA was isolated from S49 cells by the method of Herrmann and w x w x Frischauf 22 as described previously 19 .
PCR amplification of the b -adrenergic receptor 2
The b -adrenergic receptor coding sequence was 2 amplified in overlapping segments using the thermostable DNA polymerase, Pfu. One of each primer pair was synthesized with an artificial EcoRI recog-Ž .
X nition site denoted in italics on its 5 -end to facilitate cloning; 5 The PCR products were recovered by gel purification on a 1% NuSieve agarose gel, recovered using GELase, digested with EcoRI and cloned into M13mp18 for sequencing. Bluerwhite selection was applied to the M13 clones. Positive clones were sequenced using the Sequenase II kit. The b -adren-2 ergic receptor fragments were sequenced using both the Universal M13 y40 sequencing primer and sequence-specific primers.
Construction of the b -adrenergic receptor -2 pBluescript construct
The two overlapping PCR products encompassing the entire b -adrenergic receptor coding sequence 2 were recombined by PCR. Out of several strategies that we employed, this proved to be the most successful for recombining the coding sequence fragments. 0.1 ng of each fragment, amplified using the 1F X -1R and 2F-2R primers, were purified on a NuSieve 1% agarose gel, combined in a final volume of 100 ml and subjected to a single round of PCR without primers followed by an additional 24 cycles of PCR in the presence of the 1F X and 2R primers. The following temperature parameters were employed, 1 min 958C melt, 1 min 558C soak, 1 min 728C extend. The terminal extension cycle was carried out for 5 min at 728C. The 1F X primer, which lacks the artificial EcoRI site present in primer 1F, was used both to prevent primer dimer formation and to allow directional cloning. The S49 b -adrenergic receptor cod-2 ing sequence was ligated into pBluescript II SK q , the 5 X -end into the SmaI site and the 3 X -end into the EcoRI site.
Quantitation
Protein was quantitated by the method of Peterson w x using bovine serum albumin as standard 23 . DNA and RNA were quantitated by E . 
Ž
. alkylating agent, BIM Fig. 1 . Following removal of the alkylating agent, the rate of receptor recovery was measured. The initial rate of receptor recovery was slowed in the b d cells vis-a-vis the rate observed with the wild type cells.
Other than a decrease in the number of receptors and a corresponding decreased maximal ability of agonists to promote altered cyclic AMP generation, cellular regulation of cyclic AMP by both b -adren- b variants cells appears to be normal 18 . However, to corroborate this conclusion from a biochemical standpoint, the receptors were radiolabeled in situ w 125 x using I iodocyanopindololdiazirine, the photo- w 125 x w x affinity analogue of I iodocyanopindolol 24 . Following UV-irradiation of the intact cells, a crude membrane preparation that was essentially devoid of nuclear material, was prepared. The labeled membranes were electrophoresed on a discontinuous SDS-PAGE system and the covalently radiolabeled b -adrenergic receptors were visualized by auto-2 Ž . radiography Fig. 2 . Two radiolabeled bands were seen with membranes prepared from wild-type S49 cells with molecular mass of 67 000 Da and 47 000 Da. The larger molecular mass band was the major component; the smaller fragment was presumably a product of proteolytic degradation. This pattern of b -adrenergic receptor labeling is similar to that re- loldiazirine and the membrane proteins were electrophoresed on SDS-PAGE following treatment with endoglycosidase H or endoglycosidase F, as indicated. The radiolabeled receptors were visualized by autoradiography.
was confirmed several times throughout these studies w 125 x by I iodocyanopindolol binding, performed as dew x scribed previously 19 .
In addition to the decreased intensity of labeling observed with the variant cells, we observed a shift of the labeled bands toward smaller molecular mass, 60 000 and 42 000 Da in the variants vis-a-vis 67 000 Ž . and 47 000 Da in the wild-type Fig. 2 . The degree of this size shift was equivalent in the two variant cells. One possible explanation for the decrease in apparent molecular mass of the b -adrenergic is aber-2 rant receptor glycosylation since the mass of the core protein is 47 000 Da based on its deduced amino acid w x sequence 25 . Furthermore, glycosylation appears to be unimportant for b -adrenergic receptor function in 2 w x S49 cells 8 .
To determine whether altered glycosylation was indeed responsible for the decreased molecular mass, membranes prepared from photoaffinity labeled cells were treated with endoglycosidase H and N-glyco-Ž sidase F prior to fractionation on SDS-PAGE Fig. . glycosylation defect must lie upstream of the removal of mannose residues on the a arm of the high [1] [2] [3] [4] [5] [6] w x mannose structure 8 .
There are several possible explanations for aberrant glycosylation of the b -adrenergic receptor. X flanking region contains transcription factor binding sites, indicative of regulatory control of tranw x scription 2,25 . We were able to utilize PCR amplification of genomic DNA. Genomic DNA was amplified by PCR using these primer pairs and the products were cloned into M13 mp18. The PCR products thus cloned were sequenced and the sequences verified in at least two clones.
We found no differences in the coding region of the b -adrenergic receptor gene from the wild-type X non-coding sequence compared to that of the wild-type. These were loss of a T from a run of T, centered around y1660, and a T instead of a G at position y1292 in both the variant cells. These regions do not correspond to known regulatory sites and we do not know whether they functionally important in regulating receptor gene transcription. We cannot rule out the possibility that these differences may be the result of either PCR artifacts, allelic differences or of random genetic drift that has taken place in these cultured cells.
The entire S49 b -adrenergic receptor coding se-2 quence was reconstituted by performing PCR with the 1F X and 2R primers on the two fragments that together comprise the entire coding sequence. This PCR-mediated ligation, or 'jumping PCR' as it has w x also been termed 27 offers a simple way to reassemble larger DNA fragments from overlapping fragments generated by PCR. The fragment corresponding to the entire coding sequence was isolated on a low-melting temperature agarose gel and cloned into Ž . the EcoRI site in pBluescript SK q .
The sequence of the murine b -adrenergic receptor 2 gene has been determined by two groups from gew x nomic libraries of a C57BL mouse strain 3 and a w x 3T3-L1 mouse cell 25 . The S49 lymphoma cell line was derived from a tumor induced in a Balbrc w x mouse 28 . When the coding sequence of the S49 b -adrenergic receptor is aligned with that from the 2 two other murine b -adrenergic receptor sequences 2 reported, there is good accordance with only ten nucleotide differences that result in a single inferred Ž amino acid change, His or Asp, at residue 21 Table  . 1 . At least some of the sequence differences might These results provide the first example of a decreased G-protein linked receptor expression that appears to be coincidental with altered receptor sensitivity to glycosidase, consistent with altered receptor glycosylation. Both the decreased receptor expression and impaired glycosylation result from a lesion outside of the receptor's open reading frame. This observation is particularly intriguing in view of the fact that other reports have demonstrated altered glycosylation with no effect on b -adrenergic receptor 2 w x expression and function 8 . Decreased transcript expression coincident with impaired glycosylation may turn out to be a phenomenon of regulatory significance in other settings beside the expression of b -2 adrenergic and insulin receptors.
